Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
New Company Twelve Bio Aims To Improve On CRISPR Gene-Editing Tech
Cas12a Offers Advantages
Mar 09 2021
•
By
Andrew McConaghie
Gene-editing: Cas12a's small size, high specificity and ability to target sections of DNA are among its potential advantages over Cas9.
More from Gene Therapies
More from Advanced Therapies